con edison dsip Invests for Summer 2020 and New York's Clean Con Edison issuing credits to

In animal-based models of depressive-like behavior, administration of the peptide was linked to attenuation of behavioral symptoms, indicating possible antidepressant-like activity under experimental conditions (25,26)

BPC-157 is a research-stage compound without the extensive Phase I, II, and III clinical trials that FDA-approved medications undergo

It is important to note that the majority of this mechanistic research has been conducted in cell culture and animal models, with a significant proportion originating from a single research group

It appears to modulate the immune response by influencing cytokine activity and suppressing pro-inflammatory signaling